| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Lantheus Holdings, Inc. | Director | Common Stock | 28.6 K | $2.25 M | $78.50 | May 28, 2024 | Direct |
| IRONWOOD PHARMACEUTICALS INC | Director | Class A Common Stock | 164 K | $1.03 M | $6.29 | Jun 18, 2024 | Direct |
| Evelo Biosciences, Inc. | Director | Stock Option (Right to Buy) | 20 K | Jun 8, 2023 | Direct | ||
| Lantheus Holdings, Inc. | Director | Stock Option (right to buy) | 4.85 K | May 9, 2024 | Direct | ||
| AERIE PHARMACEUTICALS INC | Director | Common Stock | 0 | $15.25 | Nov 21, 2022 | Direct | |
| AERIE PHARMACEUTICALS INC | Director | Stock Option (right to buy) | 0 | $9.14 | Nov 21, 2022 | Direct |